hotspot -WSS

hotspot

author：fashion 2025-09-27 14:10:44 - browse：5

Editor’s note: A recording of the event is embedded below.

Now that biosimilar versions of Humira are starting to arrive, what happens next? Will this finally prove the case that biosimilars can deliver on big health care savings? What key signals will indicate how biosimilars might be prescribed, or paid for?

Let’s dive in and discuss what to watch in the months ahead.

Speakers:

Alex Brill, CEO, Matrix Global Advisors
Chris Brown, managing partner and co-founder, Integrity Rx Partners
Fran Gregory, PharmD, vice president of emerging therapies, Cardinal Health
Michael Gonzales, independent health care consultant, Michael Gonzales, LLC; former national and regional account director, AbbVie
Ed Silverman, Pharmalot columnist, senior writer, STAT (moderator)
Thomas Newcomer, head of U.S. market access, Samsung Bioepis (sponsor speaker)

Previous article： Medical records are filled with copy
Next article： Zyn nicotine pouches become unlikely player in latest culture war

Wikipedia

WSS

Reconstructing family trees of blood cells may help predict disease

The Affordable Care Act has saved billions in health care costs

BMS, looking to build heart drug business, turns to AI for diagnosis

How generative AI ratchets up security threats for health systems

Dozens dead from Maui wildfires: What we know about the victims

Bernie Sanders is gearing up to subpoena pharma CEOs

focus

hotspot

focus

Heart attack and stroke risk calculators need revising

Pancreatic cancer early detection could be helped by AI

In age of alternative facts, a scholarly course on calling out crap

BMS, looking to build heart drug business, turns to AI for diagnosis

Heart attack and stroke risk calculators need revising

Judge sides with young activists in first

Continuity nursing helped my family in our darkest PICU moments

Investment in vaccine development is lagging, report finds

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Bernie Sanders is gearing up to subpoena pharma CEOs

focus

New clues to why women have higher risk of autoimmune disorders

Illumina slashes 2023 revenue projections yet again

Vertex non

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

Why Medicare shouldn’t cover every FDA

Timeline: How the deadly wildfires took over Maui day by day

explore

Wikipedia

Wikipedia

entertainment